Pharmafile Logo
Pharmafocus logo
Advanced Search
biotrial_facility_rennes

Man left brain dead after clinical trial dies in hospital

January 18, 2016
Research and Development, Sales and Marketing Bial, Biotrial, clinical trial

A man left brain dead after a clinical trial in France has died in hospital and five remain in a …

News
Merck MSD

MSD sues German Merck for using name in US

January 15, 2016
Medical Communications, Sales and Marketing MSD, Merck

MSD says it is filing a lawsuit against the German company Merck “regarding their improper use of the name ‘Merck’ …

News
french_health_ministry

Clinical trial accident leaves six critical, one ‘brain dead’

January 15, 2016
Medical Communications, Research and Development France, clinical trial

Six patients have been left in a critical condition following a serious accident in a clinical trial at a French …

News
shutterstock_110597087-web

What could artificial intelligence mean for pharma?

January 15, 2016
Medical Communications artificial intelligence, digital, digital pharma, medical technology, medtech, tech

With ever rising costs in research and development, the frustratingly long time spent in bringing new novel drugs to market …

Feature
Sanofi scientist

Sanofi Pasteur to join the Human Vaccines Project

January 15, 2016
Medical Communications, Research and Development Human Vaccines Project, Sanofi Pasteur, vaccines

Sanofi Pasteur has become the latest pharma company to add funding to The Human Vaccines Project – a non-profit public-private …

News
Takeda UK

Takeda to bring UK salesforce in-house

January 15, 2016
Medical Communications, Sales and Marketing Takeda, field sales, marketing, sales, sales reps, salesforce

Takeda UK is to bring all of its sales teams and support resources in-house and reintegrate its field salesforce into …

News
abbvie

AbbVie replaces retiring VP of Western Europe and Canada

January 15, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Esteban Plata, Pascale Richetta

AbbVie has appointed Esteban Plata as vice president of Western Europe and Canada.He replaces Pascale Richetta who is retiring from …

Appointment
Researcher and patient

Patient involvement ‘would improve medicines R&D’

January 15, 2016
Medical Communications, Research and Development EUPATI, Patient and Public Involvement, R&D

A new study has revealed a belief among pharma industry executives that greater involvement of patients and the public could …

News

Wave Healthcare Communications – Four predictions for med ed in 2016

January 14, 2016
Medical Communications medical education

These are some of the trends Wave foresees in the forthcoming year: Integration We predict there will be a greater …

Feature
Thought Leadership
FDA

FDA says no to BioMarin’s Duchenne Muscular Dystrophy drug

January 14, 2016
Medical Communications, Sales and Marketing BioMarin, Duchenne Muscular Dystrophy, FDA, Kyndrisa, drisapersen

The FDA has rejected BioMarin’s Duchenne Muscular Dystrophy (DMD) drug Kyndrisa, saying there was not enough evidence that the drug …

News
Hospira logo

Pfizer may sell off Hospira unit for $2 billion

January 14, 2016
Manufacturing and Production, Medical Communications, Sales and Marketing Hospira, Pfizer, injectables, pumps

Pfizer is reportedly considering selling Hospira’s infusion pump business for around $2 billion, having acquired the injectable drugs and infusion …

News
Gavel

US Federal Trade Commission clamps down on pharma ‘pay to delay’ deals

January 14, 2016
Manufacturing and Production, Sales and Marketing Pay to delay, US Supreme Court, antitrust laws, federal trade commission, generic competition, generics, patents, pay for delay

Pharma companies were able to negotiate far fewer so-called ‘pay to delay’ cases as a strategy to stave off generic …

News
Ninlaro

Takeda in myeloma research drive

January 14, 2016
Medical Communications, Research and Development Ninlaro, Phase II, Takeda, Takeda oncology, eric low, ixazomib, multiple myeloma, myeloma

Takeda is funding the research charity Myeloma UK to run a Phase II study of its multiple myeloma treatment Ninlaro, …

News
Chemotherapy

A brighter future for the Cancer Drugs Fund?

January 14, 2016
Sales and Marketing Cancer Drugs Fund, NHS England, NICE, Prostate Cancer UK

In November 2015, NICE and NHS England announced proposed changes to the operation of the Cancer Drugs Fund. This is …

Feature
Illumina building

Illumina forms spin-off to develop cancer detection test

January 14, 2016
Research and Development Cancer, Illumina, cancer detection, gene sequencing, liquid biospy, oncology

Global gene sequencing company Illumina has won over $100 million in investment from high-profile investors, to create a company “to …

News
Baxalta logo

Baxalta’s Enbrel biosimilar measures up in late-stage study

January 13, 2016
Research and Development Amgen, Baxalta, Enbrel, Pfizer, biosimilar, etanercept, rheumatoid arthritis

Having emerged from its mega-merger deal with Shire, Baxalta is back on its drug development day job – and has …

News
Keytruda image

BioLineRx to test lead candidate with MSD’s Keytruda in pancreatic cancer

January 13, 2016
Research and Development MSD, immunotherapy, keytruda, pembrolizumab

Israeli biopharma company BioLineRx has announced a collaboration with MSD on a Phase II study investigating its lead oncology candidate, …

News
Obama_SOTU

Big pharma joins President Obama’s cancer ‘moonshot’

January 13, 2016
Research and Development Amgen, Cancer, Celgene, National Immunotherapy Coalition, President Barack Obama, US, moonshot

Celgene and Amgen are among the large biopharma companies that have agreed to join the National Immunotherapy Coalition (NIC), a …

News

Cell and Gene Therapy World: PCI Pharma Services expert to present on cold chain challenges

January 13, 2016
Medical Communications

Leading pharmaceutical provider PCI Pharma Services will bring its expertise to the stage at Cell and Gene Therapy World (January …

News
Press release
dr_robert_califf_image_via_duke_university_school_of_medicine

Senate panel approves Dr Robert Califf as FDA commissioner

January 13, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Robert Califf, FDA, FDA commissioner, Senate

A senate panel has approved president Obama’s nominee Dr Robert Califf to lead the FDA by a clear majority, although …

Appointment
The Gateway to Local Adoption Series

Latest content

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026